Micralyne, a manufacturer of biomedical MEMS and sensors, announced this week the launch MicraFluidics, a set of standardized microfluidic process technologies, to support demand from the biomedical and life-sciences industry for rapid design and deployment of integrated microfluidic based products. MicraFluidics features a variety of substrate options for biomedical customers such as silicon, glass, and silicon-on-insulator (SOI) with design flexibility for multi-level channels, electrode patterning for dielectrophoresis and embedded sensors, and choices of glass or silicon as input and output ports. This technology has been validated in a wide range of devices such as flow cells, biochips, labs-on-chip, cell sorters, separation and analysis devices, and high-pressure analytical chips.
